Pharmaceuticals for Women's Health : Global Market Outlook Report 2023

09/lug/2018 11:39:15 Sandhya Nair Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Bharat Book Bureau Provides the Trending Market Research Report on “Pharmaceuticals for Women's Health: Global Markets to 2023under Life Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects.

While Womens Health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. This report does not focus on drugs for infertility, diagnostic and drug technologies for breast cancer or therapies and diagnostics for ovarian cancer. However, we have individual reports which discusses the scope of these health concerns in detail. The report codes for these reports are listed below:


- PHM194A Drugs for Infertility: Global Markets.

- HLC143B Therapies and Diagnostics for Ovarian Cancer: Global Markets.

- HLC209A US Fertility Clinics Market.

- HLC106B Breast Cancer Diagnostic and Drug Technologies: Global Markets.

Request a free sample copy of  Pharmaceuticals for Women's Health Market Report @



Report Includes


- 26 data tables and 34 additional tables

- Detailed overview of the global markets for pharmaceuticals for women's health

- Country specific data and analysis for United States, Mexico, Germany, UK, France, China, India, Japan, Middle East and Africa

- A look at the regulatory environment which has been a driving force in the drug development industry

- Information on competitor initiatives, and information with regard to demand for chemicals

- A relevant patent analysis within the sector

- Comprehensive company profiles of major players in the market including Abbeville Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc.




Women's health has a strong presence in the global pharmaceutical market, and is expected to increase from $ xx billion in 2017 to nearly $ xx billion by 2023, at a CAGR of xx%. North America dominates the global women's health market, with a market share of xx% in 2017. North America will continue with its leading position, followed by Europe and Asia-Pacific, during the forecast period.


The postmenopausal osteoporosis segment leads the global women's health therapeutics and technologies market and will continue to significantly drive market growth, followed by pregnancy disorders and management, menopause-related conditions, endometriosis and polycystic ovary syndrome. Women's health care facilities, expanding their reproductive health into women's health areas, such as menopause-related conditions and osteoporosis. Existing therapies for these health problems have issues pertaining to safety and efficacy; for instance, hormone therapy comes with serious safety concerns. Therefore, there is a growing need for better and safer products, particularly from growing elderly populations. Osteoporosis, similar to hormone therapy, increasing demand demographic, but safety concerns have been addressed to demand that demand. The bisphosphonate category, while considered by physicians as safe and effective, has suffered considerably over the course of atypical fractures and osteonecrosis of the jaw.


Women's health and therapeutics have established a strong presence in the global pharmaceutical market. The market is expected to grow moderately, mainly due to the expiration of blockbuster drugs such as Evista, the Premarin family, Forteo, Mirena, Boniva, Actonel, Gonal-F and several others. However, the launch of new drugs in the market, and the potential to drive the market during the forecast period.


The global women's health and therapeutics market is dominated by Eli Lilly; Amgen, Inc .; Merck & Co, Inc .; AbbVie, Inc .; Bayer AG and Pfizer, Inc. A significant share of the global women's health market in 2017. Tier 1 companies dominate the market share owing to an increased preference for their product portfolio, revenue from their women's health portfolios, global sales and the company's global presence .

Browse our full report with Table of Contents:

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research provider for market research reports, company profiles, industry studies, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.


Contact us at:

Bharat Book Bureau

Tel : +91 22 27810772/27810773

Email :

Website :


Follow us on : Twitter, Facebook, LinkedIn, Google Plus

blog comments powered by Disqus è un servizio offerto da Factotum Srl